Each experiment was performed at least three times, and the data are shown as the mean SD where applicable
Because both peptides promote angiogenesis (new blood vessel growth), they are strictly contraindicated for anyone with an active malignancy or a history of cancer
LEADER Cardiovascular Outcomes Trial: The landmark cardiovascular outcome trial randomized 9,340 patients with type 2 diabetes and high cardiovascular risk to liraglutide (1.8 mg) or placebo over a median follow-up of 3.8 years
Most provincial formularies exclude obesity medications
People with a genetic predisposition to male pattern hair loss may appear to experience a sudden, dramatic loss of hair
The numerous health concerns associated with obesity, such as heart disease, diabetes, high blood pressure, and a shortened lifespan, can be reduced by losing weight and keeping it off